Screening for <i>Toxoplasma gondii</i> antibodies in 2,513 consecutive parturient women and evaluation of newborn infants at risk for congenital toxoplasmosis <b>[Abstract in English]</b>
Keywords:
CONGENITAL TOXOPLASMOSIS/PREVENTION AND CONTROL, PERINATAL INFECTIONS, MOTHER-TO-CHILD TRANSMISSION.Abstract
Aims: To determine the prevalence of seropositivity for toxoplasmosis in pregnant women, to assess the outcome and the prevalence of congenital toxoplasmosis, and to evaluate the usefulness of routine screening for Toxoplasma gondii antibodies in parturient women. Methods: Prospective cross-sectional study of consecutive mothers and their liveborn infants within the first 12 months of the implementation in a maternity ward of a routine consisting in screening for toxoplasmosis at delivery. Results: Serologic status for toxoplasmosis were assessed in 2,477 (98.5%) of 2,513 mothers of liveborn infants throughout the study period. Of the 2,477 mothers, 810 (32.7%; 95%CI 30.9-34.6%) were susceptible and 1,667 (67.3%; 95%CI 65.4-69.1%) were immune. Three newborn infants with congenital toxoplasmosis were identified because of the maternal serum tests at delivery, and all of them had active ocular lesions caused by toxoplasmic retinochoroiditis. The prevalence of congenital toxoplasmosis was 12/10,000 (CI 95%: 6/10,000-21/10,000). Conclusions: Maternal serologic screening at delivery was useful for the early detection of cases of congenital toxoplasmosis that would have otherwise gone undetected in the neonatal period, and allowed for earlier treatment of newborns with retinochoroiditis. The high prevalence of Toxoplasma gondii antibodies in pregnant women and of congenital toxoplasmosis justify a prenatal screening program in this population.Downloads
Published
How to Cite
Issue
Section
License
Copyright
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.